Publications
Detailed Information
Clinical significance of CD99 down-regulation in gastric adenocarcinoma
Cited 24 time in
Web of Science
Cited 25 time in Scopus
- Authors
- Issue Date
- 2007-05-01
- Publisher
- American Association for Cancer Research
- Citation
- Clin Cancer Res 2007;13:2584-91
- Keywords
- Adenocarcinoma/chemistry/genetics/*pathology ; Antigens, CD/analysis/*genetics ; Cell Adhesion Molecules/analysis/*genetics ; DNA Methylation ; Down-Regulation ; Female ; Humans ; Male ; Middle Aged ; Promoter Regions, Genetic ; Sp1 Transcription Factor/genetics/metabolism ; Stomach Neoplasms/chemistry/genetics/*pathology ; Gene Expression Regulation, Neoplastic ; Loss of Heterozygosity
- Abstract
- PURPOSE: CD99 is a cell adhesion molecule associated with human tumors. The aim of the present study was to characterize its role in the development and progression of human gastric adenocarcinoma. EXPERIMENTAL DESIGN: The expression of CD99 was investigated in 283 gastric adenocarcinomas and related lesions and 9 gastric carcinoma cell lines. We also analyzed the methylation status of CD99 gene by using methylation-specific PCR and examined loss of heterozygosity (LOH) of this gene locus by using an intragenic marker. Moreover, we assessed whether SP1, a positive transcription factor for CD99, is expressed in these samples. RESULTS: We found that the decreased expression of CD99 was strongly associated with poor survival and unfavorable clinicopathologic variables. Promoter region methylation (15 of 89, 16.9%) and LOH (21 of 74, 28.4%) were observed and significantly associated with CD99 down-regulation (P<0.05). In addition, most of the gastric adenocarcinoma cases with CD99 down-regulation had reduced expression of SP1 (47 of 103, 45.6%; P<0.01). This relationship between CD99 and SP1 was consolidated by using SP1 small interfering RNA transfection experiment and CD99 promoter luciferase assay. Furthermore, we showed that CD99 down-regulation was associated with proliferation and migration in gastric carcinoma cell line. CONCLUSION: These observations suggest that CD99 down-regulation is a critical event in the progression of gastric adenocarcinoma, and CD99 promoter methylation, CD99 LOH, and SP1 down-regulation were responsible for the down-regulation of CD99.
- ISSN
- 1078-0432 (Print)
- Language
- English
- URI
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17473187
https://hdl.handle.net/10371/23570
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.